Basilea Pharmaceutica
BSLN.SW
#6292
Rank
NZ$1.03 B
Marketcap
$85.78
Share price
-0.66%
Change (1 day)
18.29%
Change (1 year)

Market capitalization of Basilea Pharmaceutica (BSLN.SW)

Market cap: NZ$1.03 Billion

As of October 2024 Basilea Pharmaceutica has a market cap of NZ$1.03 Billion. This makes Basilea Pharmaceutica the world's 6292th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Basilea Pharmaceutica from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$1.03 B30.72%
2023NZ$0.79 B-14.54%
2022NZ$0.93 B19.86%
2021NZ$0.77 B-14.49%
2020NZ$0.90 B17.33%
2019NZ$0.77 B18.92%
2018NZ$0.65 B-45.35%
2017NZ$1.19 B6.34%
2016NZ$1.11 B-27.19%
2015NZ$1.53 B22.25%
2014NZ$1.25 B-14.68%
2013NZ$1.47 B158.9%
2012NZ$0.56 B21.84%
2011NZ$0.46 B-45.91%
2010NZ$0.86 B5.1%
2009NZ$0.82 B-65.08%
2008NZ$2.35 B-2.97%
2007NZ$2.42 B26.3%
2006NZ$1.92 B68.34%
2005NZ$1.14 B39.07%
2004NZ$0.82 B

End of Day market cap according to different sources

On Oct 15th, 2024 the market cap of Basilea Pharmaceutica was reported to be:

NZ$1.04 Billion
by Yahoo Finance info icon info icon
NZ$1.04 Billion
by CompaniesMarketCap info icon info icon